Positioning and reversible suppression of CCR7+ dendritic cells in perivascular tumor niches shape cancer immunity

Tumor-resident CCR7+ dendritic cells (DCs) are key determinants of antitumor T cell responses. Here, we examined the localization of CCR7+ DCs within tumors and the impact of this positioning on antitumor immunity. Spatial, single-cell, and intravital analyses of human cancers and mouse models reveal that CCR7+ DCs form perivascular clusters. Fibroblasts surrounding venous blood vessels produced CCL19, guiding CCR7+ DCs into perivascular niches. Regulatory T (Treg) cells frequently contact perivascular CCR7+ DCs, suppressing CD40 expression and CD4+ and CD8+ T cell activation. Treg cell depletion restored CD40 expression by CCR7+ DCs, enhanced immunostimulatory programs, and improved T cell-dependent tumor control. Anti-PD-1 not only increased perivascular CCR7+ DC clustering and IL-12 production but also strengthened Treg-DC interactions through a CCL22-dependent mechanism, limiting therapeutic efficacy. CCR7+ DCs expressed both co-stimulatory and co-inhibitory molecules, which may underlie their capacity for antitumor activation and concurrent vulnerability to suppression. Modulating the mechanisms that form and restrain CCR7+ DC perivascular immune hubs may improve cancer immunotherapy.

Authors

Publication Details

Journal
Open Access CRIS of the University of Bern
Published
2026-01-13
DOI
https://doi.org/10.48620/94873
Primary Topic
Chemokine receptors and signaling
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Positioning and reversible suppression of CCR7+ dendritic cells in perivascular tumor niches shape cancer immunity

Evangelia Bolli, Yuxuan Xie, David Tarussio, Nagham Alouche et al.
Open Access CRIS of the University of Bern
Chemokine receptors and signaling
article

Positioning and reversible suppression of CCR7+ dendritic cells in perivascular tumor niches shape cancer immunity

Evangelia Bolli, Yuxuan Xie, David Tarussio, Nagham Alouche, Burkhard Ludewig, Sheri A. C. McDowell, M. Kiss, Phil F. Cheng, Thorsten R. Mempel, Mehdi Hicham, William C. Faquin, Sanjiv A. Luther, Pratyaksha Wirapati, Chiara Cianciaruso, Jan Hoelzl, Sarah R. Philips, Felix Bayerl, Béatrice Zitti, Julie Terzic, Christopher Garris, Florent Duval, Dan Celestini, Ruben Bill, Tatiana V. Petrova, Ralph Weissleder, Giovanni Ciriello, Olivier Michielin, Sara I. Pai, Nawel Zouggari, Peter M. Sadow, Stephanie Tissot, Juhyun Oh, Thomas Zwahlen, Jean-Christophe Tille, Jan P. Böttcher, Sana Intidhar Labidi-Galy, Hannah M. Peterson, Michael Lanuti, Sergio Quezada, Philippa Meiser, Stephanie Hugues, Marco Varrone, Paula Nunes-Hasler, Mari Mino-Kenudson
article en

Abstract

Tumor-resident CCR7+ dendritic cells (DCs) are key determinants of antitumor T cell responses. Here, we examined the localization of CCR7+ DCs within tumors and the impact of this positioning on antitumor immunity. Spatial, single-cell, and intravital analyses of human cancers and mouse models reveal that CCR7+ DCs form perivascular clusters. Fibroblasts surrounding venous blood vessels produced CCL19, guiding CCR7+ DCs into perivascular niches. Regulatory T (Treg) cells frequently contact perivascular CCR7+ DCs, suppressing CD40 expression and CD4+ and CD8+ T cell activation. Treg cell depletion restored CD40 expression by CCR7+ DCs, enhanced immunostimulatory programs, and improved T cell-dependent tumor control. Anti-PD-1 not only increased perivascular CCR7+ DC clustering and IL-12 production but also strengthened Treg-DC interactions through a CCL22-dependent mechanism, limiting therapeutic efficacy. CCR7+ DCs expressed both co-stimulatory and co-inhibitory molecules, which may underlie their capacity for antitumor activation and concurrent vulnerability to suppression. Modulating the mechanisms that form and restrain CCR7+ DC perivascular immune hubs may improve cancer immunotherapy.

Open Access CRIS of the University of Bern
Good health and well-being
Openalex Percentile: Top 43%
Chemokine receptors and signaling
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.